Steffensen F H, Sørensen H T, Brock A, Vilstrup H, Lauritzen T
Aarhus Universitet, Sundhedsprojekt Ebeltoft, Institut for Almen Medicin og Center for Epidemiologisk Grundforskning.
Ugeskr Laeger. 1997 Sep 29;159(40):5945-50.
In a representative population sample of 905 persons we examined the prevalence of raised levels of liver-derived enzymes and its possible association with self-reported alcohol consumption adjusted for smoking and BMI applying logistic regression analyses. A large proportion of 12% (women 8%; men 16%) presented raised liver-derived enzymes. Below 21 units per week (one unit equals 12 grams of alcohol) there was no association with self-reported alcohol consumption. However, the risk of abnormal liver enzymes increased with higher consumption for both sexes; if the intake was above 28 units per week, the odds ratio for raised liver enzymes increased dramatically. Whether this subclinical biochemical liver condition is an early marker of alcohol-related liver damage remains to be seen, but the long-term consequences of the reported alcohol consumption and the frequency of raised liver enzymes require follow-up.
在一个由905人组成的具有代表性的人群样本中,我们通过逻辑回归分析,研究了肝脏衍生酶水平升高的患病率及其与自我报告的饮酒量之间的可能关联,并对吸烟和体重指数进行了调整。很大一部分人(12%,女性8%;男性16%)出现肝脏衍生酶水平升高。每周饮酒量低于21单位(1单位等于12克酒精)时,与自我报告的饮酒量无关联。然而,两性的肝脏酶异常风险均随着饮酒量增加而升高;如果每周摄入量超过28单位,肝脏酶升高的比值比会急剧增加。这种亚临床生化肝脏状况是否是酒精性肝损伤的早期标志物还有待观察,但所报告的饮酒量以及肝脏酶升高频率的长期后果需要进行随访。